Irene Ferrer
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 5%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Fibroblast Growth Factor Research 6
- Epigenetics and DNA Methylation 4
- Oncology 20
- Cancer-related Molecular Pathways 8
- Peptidase Inhibition and Analysis 4
- Cancer Immunotherapy and Biomarkers 4
- Co-authors
- Luis Paz‐Ares (34 shared papers)Jon Zugazagoitia (4 shared papers)Sonia Molina‐Pinelo (20 shared papers)Santiago Ponce (2 shared papers)Amancio Carnero (24 shared papers)Stephan Herbertz (1 shared paper)William J. John (1 shared paper)Gerald Schmid‐Bindert (1 shared paper)
- Journals
- Oncotarget (5 papers)Cancer Research (4 papers)PLoS ONE (3 papers)Journal of Thoracic Oncology (3 papers)Lung Cancer (3 papers)
- Partner nations
- SpainUnited StatesFrance
In The Last Decade
Irene Ferrer
64 papers receiving 2.3k citations
Irene Ferrer's Hit Papers
Peers
Comparison fields: 5 of 124
- Cancer Research 391
- Oncology 625
- Molecular Biology 1.1k
- Pulmonary and Respiratory Medicine 322
- Immunology 206
Countries citing papers authored by Irene Ferrer
This map shows the geographic impact of Irene Ferrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irene Ferrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irene Ferrer more than expected).
Fields of papers citing papers by Irene Ferrer
This network shows the impact of papers produced by Irene Ferrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irene Ferrer. The network helps show where Irene Ferrer may publish in the future.
Co-authors
The 25 scholars most cited alongside Irene Ferrer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Current Challenges in Cancer Treatment Hit paper breakdown → | 2016 | 683 |
| 2 | 2018 | 232 | |
| 3 | 2012 | 154 | |
| 4 | 2013 | 71 | |
| 5 | 2014 | 66 | |
| 6 | 2013 | 60 | |
| 7 | 2008 | 57 | |
| 8 | 2007 | 54 | |
| 9 | 2019 | 52 | |
| 10 | 2019 | 45 | |
| 11 | 2020 | 42 | |
| 12 | 2008 | 42 | |
| 13 | 2019 | 42 | |
| 14 | 1995 | 40 | |
| 15 | 2016 | 38 | |
| 16 | 2009 | 38 | |
| 17 | 2007 | 35 | |
| 18 | 2008 | 32 | |
| 19 | 2015 | 29 | |
| 20 | 2018 | 27 |
About Irene Ferrer
Irene Ferrer is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Immunology, having authored 65 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (8 papers), Fibroblast Growth Factor Research (6 papers), Lung Cancer Treatments and Mutations (6 papers), Epigenetics and DNA Methylation (4 papers), Peptidase Inhibition and Analysis (4 papers), Cancer-related molecular mechanisms research (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Cancer Research and Treatments (4 papers). The work is most often cited by research in Cancer Research (391 citations), Oncology (625 citations), Molecular Biology (1.1k citations), Pulmonary and Respiratory Medicine (322 citations) and Immunology (206 citations). Irene Ferrer has collaborated with scholars based in Spain, United States and France. Frequent co-authors include Luis Paz‐Ares, Jon Zugazagoitia, Sonia Molina‐Pinelo, Santiago Ponce, Amancio Carnero, Stephan Herbertz, William J. John, Gerald Schmid‐Bindert, Carmen Blanco‐Aparicio and Santiago Ramón y Cajal. Their work appears in journals such as Oncotarget, Cancer Research, PLoS ONE, Journal of Thoracic Oncology and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.